Multiple Assemblies exist for SMTL entry 8pc2
SelDeg51 in complex with FKBP51FK1 domain and pVHL:EloB:EloC; X-RAY DIFFRACTION 2.80 Å

SMTL ID
8pc2.1
Ligands
[(1~{R})-3-(3,4-dimethoxyphenyl)-1-[4-[[1-[3-[2-[[[(2~{S},4~{R})-1-[(2~{S})-2-[(1-fluoranylcyclopropyl)carbonylamino]-3,3-dimethyl-butanoyl]-4-oxidanyl-pyrrolidin-2-yl]carbonylamino]methyl]-5-(4-methyl-1,3-thiazol-5-yl)phenoxy]propyl]-1,2,3-triazol-4-yl]methoxy]phenyl]propyl] (2~{S})-1-[(2~{S})-2-cyclohexyl-2-(3,4,5-trimethoxyphenyl)ethanoyl]piperidine-2-carboxylate
Polypeptides
von Hippel-Lindau disease tumor suppressor; Elongin-C; Elongin-B; Peptidyl-prolyl cis-trans isomerase FKBP5
Oligo-state
hetero-1-1-1-1-mer
SMTL ID
8pc2.2
Ligands
[(1~{R})-3-(3,4-dimethoxyphenyl)-1-[4-[[1-[3-[2-[[[(2~{S},4~{R})-1-[(2~{S})-2-[(1-fluoranylcyclopropyl)carbonylamino]-3,3-dimethyl-butanoyl]-4-oxidanyl-pyrrolidin-2-yl]carbonylamino]methyl]-5-(4-methyl-1,3-thiazol-5-yl)phenoxy]propyl]-1,2,3-triazol-4-yl]methoxy]phenyl]propyl] (2~{S})-1-[(2~{S})-2-cyclohexyl-2-(3,4,5-trimethoxyphenyl)ethanoyl]piperidine-2-carboxylate
Polypeptides
von Hippel-Lindau disease tumor suppressor; Elongin-C; Elongin-B; Peptidyl-prolyl cis-trans isomerase FKBP5
Oligo-state
hetero-1-1-1-1-mer